Factor | Wait-Listed Patients | Univariate Odds Ratio for Polycystic Kidney Disease | Adjusted Odds Ratio for Polycystic Kidney Disease In Logistic Regression (95% CI)B |
---|---|---|---|
N | 40,493 | ||
PKD | 2949 | ||
Male | 24,143 (59.6) | 0.89 (0.83–0.97) | 0.89 (0.79–0.99) |
African American | 11,193 (27.6) | 0.27 (0.24–0.31) | 0.25 (0.22–0.30) |
Year of First Dialysis | 1996.5 ± 1.1 | 1.02 (1.02–1.03) | |
Mean Age (Years) | 45.6 ± 13.9 | 0.98 (0.97–0.99) | |
Mean Followup (Years) | 1.4 ± 1.0 | ||
Renal Transplantation | 16,327 | 1.48 (1.38–1.59) | 1.23 (1.10–1.39) |
Continuous Variables from Medical Evidence Form, 2728 (at initiation of dialysis): B | |||
Recipient Weight (in kg) | 75.7 ± 13.7 | 1.01 (1.01–1.02) | |
Body Mass Index (kg/m2) | 25.8 ± 4.9 | 1.02 (1.01–1.03) | |
Hematocrit (%) | 28.2 ± 5.5 | 1.04 (1.03–1.05) | |
Hemoglobin (gm/dl) | 9.5 ± 1.9 | ||
Serum Albumin (gm/dl) | 3.4 ± 0.6 | 2.67 (2.41–2.96) | |
Serum Creatinine (mg/dl) | 10.0 ± 4.4 | 0.97 (0.95–0.98) | |
BUN (mg/dl) | 94.4 ± 33.5 | ||
Categorical Variables from the Medical Evidence Form (2728), history of: | |||
COPD | 615 (1.5) | 0.68 (0.47–0.97) | 0.60 (0.37–0.96) |
Congestive Heart Failure | 4621 (11.4) | 0.18 (0.15–0.23) | 0.31 (0.23–0.41) |
Ischemic Heart Disease | 3179 (7.9) | 0.58 (0.49–0.69) | 0.69 (0.54–0.88) |
Myocardial Infarction | 1105 (2.7) | 1.67 (1.17–2.38) | |
Peripheral vascular disease | 1879 (4.6) | 0.19 (0.13–0.27) | 0.34 (0.22–0.54) |
Diabetes (Primary) | 8068 (22.1) | 0.07 (0.05–0.09) | 0.59 (0.44–0.79) |
Hypertension | 26,658 (73) | ||
Cancer | 451 (1.1) | 0.41 (0.25–0.67) | |
Alcohol use | 373 (0.9) | 0.31 (0.16–0.61) | 0.42 (0.20–0.88) |
Pre dialysis EPO | 11,108 (30.4) | 1.10 (1.01–1.20) | |
Hemodialysis (vs. Peritoneal Dialysis) | 28,003 (76.7) | 0.88 (0.80–0.96) |